EMA — authorised 22 July 2014
- Marketing authorisation holder: Octapharma AB
- Status: approved
🇪🇺 Nuwiq in European Union
EMA authorised Nuwiq on 22 July 2014
Marketing authorisation
Nuwiq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in European Union
Frequently asked questions
Is Nuwiq approved in European Union?
Yes. EMA authorised it on 22 July 2014.
Who is the marketing authorisation holder for Nuwiq in European Union?
Octapharma AB holds the EU marketing authorisation.